CARAVAGGIO Trial: Is Apixaban safe and efficacious in Cancer Venous Thromboembolism?--NEJM April 2020
Dr RR Baliga's "Got Knowledge Doc" Podkast · MasterMedFacts.com
October 5, 202212m 43s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians| CARAVAGGIO Trial: Is Apixaban safe and efficacious in Cancer Venous Thromboembolism?-NEJM April 2020 | Not Medical Advice or Opinion
- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer N Engl J Med 2020; 382:1599-1607
- Anticoagulant Therapy for Venous Thromboembolism in Cancer N Engl J Med 2020; 382:1650-1652
- Tukaye DN, Brink H, Baliga R. Venous thromboembolism in cancer patients: risk assessment, prevention and management. Future Cardiol. 2016;12(2):221‐235. doi:10.2217/fca.15.87
- Arcopinto M, Cella CA, Wesolowski R, et al. Primary prevention of cancer-related thrombosis: special focus on ambulatory patients. Int J Cardiol. 2014;173(3):583‐584. doi:10.1016/j.ijcard.2014.03.109